Literature DB >> 7679219

Locomotor activity in mice during chronic treatment with caffeine and withdrawal.

O Nikodijević1, K A Jacobson, J W Daly.   

Abstract

Chronic ingestion of caffeine by mice caused a marked reduction in locomotor exploratory activity. At least 4 days of withdrawal were required to restore activity to normal levels. Stimulatory effects of injected caffeine were lower in chronically treated mice and the biphasic dose-response (stimulatory followed by depressant) curve for injected caffeine was left shifted. Seven days of withdrawal were required before the dose-response curve to caffeine was identical to that of control mice. The depressant effects of a potent xanthine phosphodiesterase inhibitor, 1,3-dipropyl-7-methylxanthine, were blunted in caffeine-treated mice. The depressant effects of A1- and A2-selective adenosine analogs were enhanced after chronic caffeine. There was little or no effect of chronic caffeine on the stimulatory effects of dopaminergic agents (amphetamine, caffeine), while both depressant and stimulatory effects of cholinergic agents (nicotine, oxotremorine, scopolamine) were reduced. The results indicate that chronic caffeine affects functions of adenosine and cholinergic receptors related to regulation of locomotor exploratory activity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7679219      PMCID: PMC3557839          DOI: 10.1016/0091-3057(93)90299-9

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  45 in total

1.  Effect of caffeine on cocaine locomotor stimulant activity in rats.

Authors:  A L Misra; N L Vadlamani; R B Pontani
Journal:  Pharmacol Biochem Behav       Date:  1986-03       Impact factor: 3.533

2.  Up-regulation of brain [3H]diazepam binding sites in chronic caffeine-treated rats.

Authors:  P H Wu; V L Coffin
Journal:  Brain Res       Date:  1984-02-27       Impact factor: 3.252

3.  Caffeine tolerance: behavioral, electrophysiological and neurochemical evidence.

Authors:  D T Chou; S Khan; J Forde; K R Hirsh
Journal:  Life Sci       Date:  1985-06-17       Impact factor: 5.037

4.  Cross-tolerance studies between caffeine and (-)-N6-(phenylisopropyl)-adenosine (PIA) in mice.

Authors:  M K Ahlijanian; A E Takemori
Journal:  Life Sci       Date:  1986-02-17       Impact factor: 5.037

5.  Chronic caffeine ingestion sensitizes the A1 adenosine receptor-adenylate cyclase system in rat cerebral cortex.

Authors:  R M Green; G L Stiles
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

6.  Chronic caffeine treatment reduces caffeine but not adenosine effects on cortical acetylcholine release.

Authors:  R Corradetti; F Pedata; G Pepeu; M G Vannucchi
Journal:  Br J Pharmacol       Date:  1986-07       Impact factor: 8.739

7.  Caffeine pretreatment: enhancement and attenuation of d-amphetamine-induced activity.

Authors:  B C White; G E Keller
Journal:  Pharmacol Biochem Behav       Date:  1984-03       Impact factor: 3.533

8.  Behavioral characteristics of centrally administered adenosine analogs.

Authors:  J W Phillis; R A Barraco; R E DeLong; D O Washington
Journal:  Pharmacol Biochem Behav       Date:  1986-02       Impact factor: 3.533

9.  Antagonism of the behavioral effects of L-phenylisopropyladenosine (L-PIA) by caffeine and its metabolites.

Authors:  L Logan; J M Carney
Journal:  Pharmacol Biochem Behav       Date:  1984-09       Impact factor: 3.533

10.  Behavioral effects of caffeine, (-)N-((R)-1-methyl-2-phenylethyl)-adenosine (PIA), and their combination in the mouse.

Authors:  J R Glowa; E Sobel; S Malaspina; P B Dews
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

View more
  24 in total

Review 1.  Mechanisms of the psychostimulant effects of caffeine: implications for substance use disorders.

Authors:  Sergi Ferré
Journal:  Psychopharmacology (Berl)       Date:  2016-01-20       Impact factor: 4.530

Review 2.  Caffeine use in children: what we know, what we have left to learn, and why we should worry.

Authors:  Jennifer L Temple
Journal:  Neurosci Biobehav Rev       Date:  2009-01-20       Impact factor: 8.989

3.  Caffeine alters proliferation of neuronal precursors in the adult hippocampus.

Authors:  Christian T Wentz; Sanjay S P Magavi
Journal:  Neuropharmacology       Date:  2009-02-13       Impact factor: 5.250

4.  Adenosine A(2A) receptors are necessary and sufficient to trigger memory impairment in adult mice.

Authors:  N Pagnussat; A S Almeida; D M Marques; F Nunes; G C Chenet; P H S Botton; S Mioranzza; C M Loss; R A Cunha; L O Porciúncula
Journal:  Br J Pharmacol       Date:  2015-06-26       Impact factor: 8.739

5.  Chronic effects of xanthines on levels of central receptors in mice.

Authors:  D Shi; J W Daly
Journal:  Cell Mol Neurobiol       Date:  1999-12       Impact factor: 5.046

Review 6.  The Impact of Caffeine on the Behavioral Effects of Ethanol Related to Abuse and Addiction: A Review of Animal Studies.

Authors:  Laura López-Cruz; John D Salamone; Mercè Correa
Journal:  J Caffeine Res       Date:  2013-03

7.  The role of adenosine receptors in the central action of caffeine.

Authors:  John W Daly; Dan Shi; Olga Nikodijevic; Kenneth A Jacobson
Journal:  Pharmacopsychoecologia       Date:  1994

8.  Deletion of striatal adenosine A(2A) receptor spares latent inhibition and prepulse inhibition but impairs active avoidance learning.

Authors:  Philipp Singer; Catherine J Wei; Jiang-Fan Chen; Detlev Boison; Benjamin K Yee
Journal:  Behav Brain Res       Date:  2012-12-28       Impact factor: 3.332

9.  The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptors.

Authors:  M El Yacoubi; C Ledent; J F Ménard; M Parmentier; J Costentin; J M Vaugeois
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

Review 10.  Pharmacological rationale for the clinical use of caffeine.

Authors:  J Sawynok
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.